| Deborah A King, | |
|
10000 W 75th St Ste 121, Shawnee Mission, KS 66204-2241 | |
| (913) 362-7518 | |
| (913) 362-7302 |
| Full Name | Deborah A King |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 49 Years |
| Location | 10000 W 75th St Ste 121, Shawnee Mission, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518987569 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 206 (Kansas) | Primary |
| 235Z00000X | Speech-language Pathologist | 00742 (Missouri) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Deborah A King Ma And Associates Inc | 9931091485 | 15 |
| Deborah A King Ma And Associates Inc | 9931091485 | 15 |
News Archive
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
Drug-eluting stents are just as safe and effective as traditional bare-metal stents when used in routine clinical practice, according to a new study by researchers at Rhode Island Hospital.
For the 700 million women, men and children in the least developed countries (LDCs), United Nations' decisions - and their follow-up - could mean the difference between opportunity and poverty, peace and war, life and death
› Verified 1 days ago
| Provider Name | Deborah A King Ma & Associates Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942408950 PECOS PAC ID: 9931091485 Enrollment ID: O20040329000602 |
News Archive
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
Drug-eluting stents are just as safe and effective as traditional bare-metal stents when used in routine clinical practice, according to a new study by researchers at Rhode Island Hospital.
For the 700 million women, men and children in the least developed countries (LDCs), United Nations' decisions - and their follow-up - could mean the difference between opportunity and poverty, peace and war, life and death
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah A King, 10000 W 75th St Ste 121, Shawnee Mission, KS 66204-2241 Ph: (913) 362-7518 | Deborah A King, 10000 W 75th St Ste 121, Shawnee Mission, KS 66204-2241 Ph: (913) 362-7518 |
News Archive
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today unveiled Microcyn Solution with preservatives, at the New York Podiatric Clinical Conference & Exhibition being held in downtown Manhattan, January 29-31.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
Drug-eluting stents are just as safe and effective as traditional bare-metal stents when used in routine clinical practice, according to a new study by researchers at Rhode Island Hospital.
For the 700 million women, men and children in the least developed countries (LDCs), United Nations' decisions - and their follow-up - could mean the difference between opportunity and poverty, peace and war, life and death
› Verified 1 days ago
Samantha Hance, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518 Fax: 913-362-7302 | |
Andrea Onnen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W. 75th Street, Suite 121, Shawnee Mission, KS 66204 Phone: 913-362-7518 | |
Norma Kendrick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518 Fax: 913-362-7302 | |
Karen Hetrick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518 Fax: 913-362-7302 | |
Mary Ellen Lubow, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518 Fax: 913-362-7302 | |
Denise Treece, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518 Fax: 913-362-7302 | |
Michele Todtfeld, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518 Fax: 913-362-7302 |